Suppr超能文献

给绵羊饲喂苜蓿草料时胃肠道对氨基酸的利用情况。

Amino acid use by the gastrointestinal tract of sheep given lucerne forage.

作者信息

MacRae J C, Bruce L A, Brown D S, Calder A G

机构信息

Rowett Research Institute, Bucksburn, Aberdeen, Scotland, United Kingdom.

出版信息

Am J Physiol. 1997 Dec;273(6):G1200-7. doi: 10.1152/ajpgi.1997.273.6.G1200.

Abstract

Essential amino acid (EAA) utilization by gastrointestinal tract (GIT) tissues has been investigated in sheep given 800 and 1,200 g/day lucerne pellets. Animals prepared with indwelling catheters into the aorta and the portal drained viscera plus cannulas into the small intestine were infused with mixed U-13C-labeled amino acid or (1-13C]leucine tracers into the jugular vein or directly into the small intestine. GIT sequestration of EAA from arterial and luminal AA pools was determined from tracer and tracee arterioportal concentration differences at both levels of intake. Proportional tracer 13C-labeled EAA extraction of the arterial supply, on first pass across the GIT during jugular infusion, ranged from 0.063 for histidine to 0.126 for leucine. Recovery of intestinally infused tracer 13C-EAA at the portal vein ranged from 0.61 for histidine to 0.83 for valine. These data were independent of intake. Calculated rates of tracee sequestration by GIT tissues represented 0.45-0.65 of whole body EAA flux, except for histidine, for which the values were much lower (0.25-0.32). With the exception of phenylalanine, more than 0.8 of the EAA used by the GIT was extracted from circulating blood, thus calling into question the theory that GIT tissues make preferential use of EAA during absorptive metabolism, restricting supply to peripheral tissues such as skeletal muscle (growth) or mammary glands (lactation). Instead the GIT seems to compete very successfully with these tissues for circulating blood EAA.

摘要

在给绵羊每日饲喂800克和1200克苜蓿颗粒的情况下,研究了胃肠道(GIT)组织对必需氨基酸(EAA)的利用情况。对通过主动脉和门静脉引流内脏的留置导管以及小肠插管制备的动物,经颈静脉或直接向小肠注入混合的U-13C标记氨基酸或[1-13C]亮氨酸示踪剂。根据两种摄入量水平下示踪剂和被示踪物的动脉-门静脉浓度差异,测定了GIT从动脉和肠腔氨基酸池中对EAA的截留情况。在颈静脉输注期间,示踪剂首次通过GIT时,动脉供应中13C标记EAA的比例提取率范围为:组氨酸为0.063,亮氨酸为0.126。门静脉处肠内注入的示踪剂13C-EAA的回收率范围为:组氨酸为0.61,缬氨酸为0.83。这些数据与摄入量无关。GIT组织对被示踪物的截留率计算值占全身EAA通量的0.45-0.65,但组氨酸除外,其值要低得多(0.25-0.32)。除苯丙氨酸外,GIT使用的EAA中超过0.8是从循环血液中提取的,因此,关于GIT组织在吸收性代谢过程中优先利用EAA,从而限制对骨骼肌(生长)或乳腺(泌乳)等外周组织供应的理论受到质疑。相反,GIT似乎在与这些组织竞争循环血液中的EAA方面非常成功。

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验